KTP - GlaxoSmithKline plc. Understanding the different polymorphs in APIs which impact stability and biopharmaceutics.

Project: Research

Project Details

StatusFinished
Effective start/end date1/09/22 → 31/08/24

Funding

  • Glaxo Smithkline (UK)
  • Innovate UK: £93,633.00